DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0013336 | Dwarfism | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0023520 | Leukodystrophy | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0005697 | Neurogenic Urinary Bladder | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0235946 | Cerebral atrophy | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C3714756 | Intellectual Disability | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0013421 | Dystonia | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C2239176 | Liver carcinoma | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0023467 | Leukemia, Myelocytic, Acute | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C4721453 | Peripheral Nervous System Diseases | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0007758 | Cerebellar Ataxia | ACER3 | 55331 | alkaline ceramidase 3 | Q9NUN7 |
C0751494 | Convulsive Seizures | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0220743 | Childhood hypophosphatasia (disorder) | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0020630 | Hypophosphatasia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0520739 | Hereditary pyropoikilocytosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0001787 | Osteoporosis, Age-Related | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0268413 | Adult hypophosphatasia (disorder) | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0004153 | Atherosclerosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0268412 | Infantile hypophosphatasia | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0494475 | Tonic - clonic seizures | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0751495 | Seizures, Focal | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0011334 | Dental caries | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0010054 | Coronary Arteriosclerosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0029456 | Osteoporosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0010278 | Craniosynostosis | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
C0553730 | Calcium pyrophosphate deposition disease | ALPL | 249 | alkaline phosphatase, biomineralization associated | P05186 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024